|
总之，用常规细胞学涂片进行免疫化学检测HPV L1壳蛋白可以作为HPV感染阳性病人的风险评估和预后判定的特异性临床生物标志物。建议对于HPV-DNA分型检测高危阳性的患者需同时进行HPV L1的检测，其中对于HPV L1检测结果阴性的患者需行阴道镜检查。
【参考文献】
[1] Wright TC Jr, Massad LS, Dunton CJ, et al. 2006 Consensus guidelines for the management of women with abnormal cervical cancer screening tests [J]. Am J Obstet Gynecol, 2007,197(4):346-355.
[2] Future ⅡStudy Group. Quadrivalent vaccine against human papillomavirus to prevent high grade cervical lesions[J]. N Engl J Med, 2007,356:1915-1927.
[3] Clifford GM, Smith JS, Aguado T, et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis [J]. Br J Cancer, 2003, 89:101-105.
[4] 潘保见，陈嘉薇，祝 峰. 宫颈鳞癌和癌前病变中eIF-4E表达及其与HPV16/18感染的关系[J]. 临床与实验病理学杂志，2007,23(5):528-531.
[5] Guido R, Schiffman M, Solomon D, et al. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesion or human papillomavirus DNA-positive atypical squamous cells of undermined significance: a two-year prospective study [J]. Am J Obstet Gynecol, 2003,188(6):1401-1405.
[6] Tomomi Yoshida.Immunochemical analysis of HPV L1 capsid protein and P16 protein in liquid-based cytology samples from uterine cervical lesions[J]. Cancer Cytopathol,2008;114:83-88.
[7] 刘朝齐，许雪梅，徐建青，等. 人乳头瘤病毒16型晚期基因L1在原核细胞的表达及免疫效果观察[J]. 中国妇幼保健，2007, 22:5028-5032.
[8] Melsheimer P. Immunocytochemical detection of HPV high-risk type L1 capsid proteins in LSIL and HSIL as compared with detection of HPV L1 DNA[J]. Acta Cytol,2003,47: 124-128
[9] Griesser H. Correlation of immunochemical detection of HPV L1 capsid protein in pap smears with regression of high-risk HPV positive mild/moderate dysplasia[J]. Anal Quant Cytol Histol,2004, 26:241-245.
[10] 范江涛，陈心秋，张 卉. 表达HPV16L1、L2和E7蛋白的非复制重组痘苗病毒诱发的抗肿瘤免疫反应[J]. 中国免疫学杂志，2009, 25:317-320.
|